每月一次使用阿里皮普拉治疗双极性障碍:从症状稳定到功能恢复
Hye Ryun Yang1, Sra Jung2, Jiwan Moon1
1Department of Psychiatry, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Psychiatry investigation
|December 17, 2025
概括
每月注射阿里皮普拉可显著改善功能和减少症状在韩国双相情感障碍患者超过一年. 这种长效的注射治疗也减少了对其他情绪稳定剂和抗精神病药物的需求.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
- 临床研究 临床研究
背景情况:
- 药物坚持对于长期管理双相情绪障碍至关重要.
- 每月服用阿里皮普拉长效注射剂 (LAI) 越来越多地用于改善坚持和管理双相情感障碍.
- 有限的研究存在于南韩双相情感障碍患者的阿里皮普拉LAI的有效性.
研究的目的:
- 评估每月一次的阿里皮普拉在韩国双相情感障碍患者的疗效.
- 评估阿里皮普拉LAI对功能结果和症状严重性的影响.
- 分析在阿里皮普拉LAI治疗期间同时使用药物的变化.
主要方法:
- 一项非干预性,回顾性研究分析了用阿里皮普拉LAI治疗双相情感障碍患者的医疗记录.
- 数据收集发生在启动后的1,3,6,9和12个月.
- 标准化尺度 (GAF,CGI-BP-S,YMRS,K-MADRS,HAM-A) 测量了功能和症状变化;药物剂量也被记录下来.
主要成果:
- 在12个月的全球功能评估 (GAF) 成绩中观察到显著的改善 (+25.7%,p=0.001).
- 症状严重程度得分显著降低,包括CGI-BP-S (-24.4%),YMRS (-81.2%),K-MADRS (-36.2%) 和HAM-A (-36.1%) (所有p<0.003).
- 总药丸数量和同时服用情绪稳定剂和抗精神病药物的剂量有显著下降.
结论:
- 每月一次的阿里皮普拉治疗显示,双相情绪障碍患者的功能结果和情绪症状显著改善.
- 阿里皮普拉LAI有助于减少对其他精神病药物的需求.
- 这些发现强调了长效注射抗精神病药物在改善双相情感障碍管理中的整体幸福感和治疗坚持度方面的价值.
相关概念视频
Mania and Antimanic Drugs: Overview
526
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
526
Psychosis: Goals of Pharmacotherapy
441
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
441
Bipolar Disorder
591
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
591
Psychosis and Antipsychotic Drugs: Overview
776
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
776
Drug Therapy
232
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
232
Antidepressant Drugs: MAOIs and Other Agents
770
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
770


